Genomic Uniformed-Screening Against Rare Disease In All Newborns

Summary

The goal of this study is to learn how genomic sequencing technology can be used to effectively expand the conditions screened on newborn screening. Newborn screening ensures equity and allows all babies to have the same chance at the healthiest life. Families will be invited to have their newborn baby screened for additional conditions beyond what all babies are screened for as part of the newborn screening public health program. Families can choose to be part of the study or choose not to be part of the study and just have the routine newborn screening test.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Early Onset Genetic Conditions With Near Complete Penetrance

Eligibility basics and study details

Study type

Interventional

Phase

Not applicable

Ages

1 day to 1 month

Sex

All

Healthy volunteers

Accepted

Sponsor

Columbia University

Last updated on ClinicalTrials.gov

September 21, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites